Original Research Papers
​
1. N.G. Than, B. Sümegi, G.N. Than, Z. Berente, H. Bohn:
​
On the TOP - Most downloaded paper
​
The most downloaded article
At Placenta
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
​
Original Research Papers
​​
1. N.G. Than, B. Sümegi, G.N. Than, Z. Berente, H. Bohn:
Isolation and sequence analysis of a cDNA encoding human placental tissue protein 13 (PP13), a new lysophospholipase, homologue of the human eosinophil Charcot-Leyden crystal protein. Placenta, 20, 703-710, 1999.
Impact factor: 2.101
​​
2. N.G. Than, E. Pick, Sz. Bellyei, A. Szigeti, O. Burger, Z. Berente, T. Janáky, Á. Boronkai, H. Kliman, H. Meiri, H. Bohn, G.N. Than, B. Sümegi:
Functional analyses of placental protein 13 (PP13) / galectin-13.
European Journal of Biochemistry, 271, 1065-1078, 2004.
Impact factor: 3.260
​
3. O. Erez, R. Romero, J. Espinoza, W. Fu, D. Todem, J.P. Kusanovic, F. Gotsch, S. Edwin, J.K. Nien, T. Chaiworapongsa, P. Mittal, S. Mazaki-Tovi,
N.G. Than, R. Gomez, S.S. Hassan:
The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.
Journal of Maternal-Fetal & Neonatal Medicine, 21, 279-287, 2008.
Impact factor: 1.089
​
4. R. Romero, J.P. Kusanovic, N.G. Than, O. Erez, F. Gotsch, J. Espinoza, S. Edwin, I. Chefetz, R. Gomez, J.K. Nien, M. Sammar, B. Pineles, S.S. Hassan, H. Meiri, Y. Tal, I. Kuhnreich, Z. Papp, H.S. Cuckle:
First trimester maternal serum PP13 in the risk assessment for preeclampsia.
American Journal of Obstetrics and Gynecology, 199, 122.e1-122.e11, 2008.
Impact factor: 3.453
​
5. O. Erez, R. Romero, S.S. Kim, J.S. Kim, Y.M. Kim, D.E. Wildman, N.G. Than, S. Mazaki-Tovi, F. Gotsch, B. Pineles, J.P. Kusanovic, J. Espinoza, P. Mittal, M. Mazor, S.S. Hassan, C.J. Kim:
Over-expression of thrombin receptor (PAR-1) in the placenta in preeclampsia: A mechanism for the intersection of coagulation and inflammation.
Journal of Maternal-Fetal & Neonatal Medicine, 21, 345-355, 2008.
Impact factor: 1.089
​​
6. N.G. Than, O. Erez, D.E. Wildman, A.L. Tarca, S.S. Edwin, A. Abbas, J. Hotra, J.P. Kusanovic, F. Gotsch, S.S. Hassan, J. Espinoza, Z. Papp, R. Romero:
Severe preeclampsia is characterized by increased placental expression of galectin-1.
Journal of Maternal-Fetal & Neonatal Medicine, 21, 429–442, 2008.
Impact factor: 1.089
​
7. N.G. Than, R. Romero, O. Erez, J.P. Kusanovic, A.L. Tarca, S. Edwin, J.S. Kim, S.S. Hassan, J. Espinoza,
P. Mittal, S. Mazaki-Tovi, L. Friel, F. Gotsch, E. Vaisbuch, N. Camacho, Z. Papp:
A role for mannose-binding lectin, a component of the innate immune system in pre-eclampsia.
American Journal of Reproductive Immunology, 60, 333-345, 2008.
Impact factor: 2.172
​
8. N.G. Than, O.A. Rahman, R. Magenheim, B. Nagy, T. Fule, B. Hargitai, M. Sammar, P. Hupuczi, A.L. Tarca, G. Szabo, I. Kovalszky, H. Meiri, I. Sziller, R. Romero, J. Rigo, Z. Papp:
Placental Protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm preeclampsia and HELLP syndrome.
Virchows Archiv, 453, 387-400, 2008.
Impact factor: 2.082
​
9. O. Erez, R. Romero, D. Hoppensteadt, N.G. Than, J. Fareed, S. Mazaki-Tovi, J. Espinoza, T. Chaiworapongsa, S.S. Kim, B.H. Yoon, S.S. Hassan, F. Gotsch, L. Friel, E. Vaisbuch, J.P. Kusanovic:
Tissue factor and its natural inhibitor in preeclampsia and SGA.
Journal of Maternal-Fetal & Neonatal Medicine, 21, 855-869, 2008.
Impact factor: 1.089
​
10. S. Mazaki-Tovi, R. Romero, E. Vaisbuch, J.P. Kusanovic, O. Erez, F. Gotsch, T. Chaiworapongsa, N.G. Than, S.K. Kim, C.L. Nhan-Chang, C. Jodicke, P. Pacora, L. Yeo, Z. Dong, B.H. Yoon, S.S. Hassan, P. Mittal:
Maternal serum adiponectin multimers in preeclampsia.
Journal of Perinatal Medicine, 37, 349-363, 2009.
Impact factor: 1.736
​
11. N.G. Than, R. Romero, M. Goodman, A. Weckle, J. Xing, Z. Dong, Y. Xu, F. Tarquini, A. Szilagyi, P. Gal, Z. Hou, A.L. Tarca, C.J. Kim, J.S. Kim, S. Haidarian, M. Uddin, H. Bohn, K. Benirschke, J. Santolaya-Forgas, L.I. Grossman,
O. Erez, S.S. Hassan, P. Zavodszky, Z. Papp, D.E. Wildman:
A primate subfamily of galectins expressed at the maternal–fetal interface that promote immune cell death.
Proceedings of the National Academy of Sciences of the USA, 106, 9731-9736, 2009.
Impact factor: 9.432
​​
12. O. Erez, R. Romero, E. Vaisbuch, S. Mazaki-Tovi, J.P. Kusanovic, T. Chaiworapongsa, N.G. Than, F. Gotsch, C.J. Kim, P. Mittal, S. Edwin, P. Pacora, S.K. Kim, L. Yeo, M. Mazor, S.S. Hassan:
Maternal anti-protein Z antibodies in pregnancies complicated by pre-eclampsia, SGA and fetal death.
Journal of Maternal-Fetal & Neonatal Medicine, 22, 662-671, 2009.
Impact factor: 1.362
​​
13. E. Vaisbuch, R. Romero, S. Mazaki-Tovi, O. Erez, S.K. Kim, T. Chaiworapongsa, F. Gotsch, N.G. Than, Z. Dong, P. Pacora, R. Lamont, L. Yeo, S.S. Hassan, J.P. Kusanovic:
Retinol binding protein 4 - a novel association with early-onset preeclampsia.
Journal of Perinatal Medicine, 38, 129-139, 2010.
Impact factor: 1.871
​
14. S. Mazaki-Tovi, R. Romero, S.K. Kim, E. Vaisbuch, J.P. Kusanovic, O. Erez, T. Chaiworapongsa, F. Gotsch, P. Mittal, C.L Nhan-Chang, N.G. Than, R. Gomez, J.K. Nien, S.S. Edwin, P. Pacora, L. Yeo, S.S. Hassan:
Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA?
Journal of Maternal-Fetal & Neonatal Medicine, 23, 857-868, 2010.
Impact factor: 2.071
​
15. T. Chaiworapongsa, R. Romero, J.P. Kusanovic, P. Mittal, S.K. Kim, F. Gotsch, N.G. Than, S. Mazaki-Tovi, E. Vaisbuch, O. Erez, L. Yeo, S.S. Hassan, Y. Sorokin:
Plasma soluble endoglin concentration in pre-eclampsia is associated with an increased impedance to flow in the maternal and fetal circulations.
Ultrasound in Obstetrics & Gynecology, 35, 155-162, 2010.
Impact factor: 3.163
​
16. T. Varkonyi, L. Lazar, A. Molvarec, N.G. Than, J. Rigo Jr, B. Nagy B:
Leptin receptor (LEPR) SNP polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analysis.
BMC Medical Genetics, 11, 25, 2010.
Impact factor: 2.439
​
17. T. Varkonyi, B. Nagy, T. Fule, A.L. Tarca, K. Karaszi, J. Schonleber, P. Hupuczi, N. Mihalik, I. Kovalszky, J. Rigo Jr., H. Meiri, Z. Papp, R. Romero, N.G. Than:
Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar.
Placenta, 32, S21-S29, 2011.
Impact factor: 3.693
​
18. A. Balogh, J. Pozsgay, J. Matkó, Z. Dong, C.J. Kim, T. Várkonyi, M. Sammar, J. Rigó., H. Meiri, R. Romero, Z. Papp, N.G. Than:
Placental Protein 13 (PP13/galectin-13) undergoes lipid raft-associated subcellular redistribution in the syncytiotrophoblast in preterm preeclampsia and HELLP syndrome.
American Journal of Obstetrics and Gynecology, 205, 156.e1-14, 2011.
Impact factor: 3.468
​
19. N.G. Than, R. Romero H. Meiri, O. Erez, Y. Xu, F. Tarquini, L. Barna, A. Szilágyi, R. Ackerman, M. Sammar, T. Füle, K. Karaszi, I. Kovalszky, Z. Dong, C.J. Kim, P. Závodszky, Z. Papp, R. Gonen:
PP13, maternal ABO blood groups and the risk assessment of pregnancy complications.
PLoS ONE, 6, e21564, 2011.
Impact factor: 4.092
​
20. T. Chaiworapongsa, R. Romero, S.J. Korzeniewski, J.P. Kusanovic, E. Soto, J. Lam, Z. Dong, N.G. Than, L. Yeo, E. Hernandez-Andrade, A. Conde-Agudelo, S.S. Hassan:
Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.
American Journal of Obstetrics and Gynecology, 208, 287.e1-287.e15. 2013.
Impact factor: 3.973
​
21. Sz. Szabo, Y. Xu, R. Romero, T. Fule, K. Karaszi, G. Bhatti, T. Varkonyi, I. Varkonyi, T. Krenacs, Z. Dong, A.L. Tarca, T. Chaiworapongsa, S.S. Hassan, Z. Papp, I. Kovalszky, N.G. Than:
Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome.
Virchows Archiv, 463, 445-458, 2013.
Impact factor: 2.560
​
22. P. Chaemsaithong, T. Chaiworapongsa, R. Romero, S.J. Korzeniewski, T. Stampalija, N.G. Than, Z. Dong, J. Miranda, L. Yeo, S.S. Hassan:
Maternal plasma soluble TRAIL is decreased in preeclampsia.
Journal of Maternal-Fetal & Neonatal Medicine, 27, 217-227, 2014.
Impact factor: 1.367
​
23. O. Erez, L. Novack, R. Beer-Weisel, D. Dukler, F. Press, A. Zlotnik, N.G. Than, A. Tomer, M. Mazor:
DIC score in pregnant women – A population based modification of the International Society on Thrombosis and Hemostasis Score.
PLoS ONE, 9(4): e93240, 2014.
Impact factor: 3.234
​
24. N.G. Than, R. Romero, Y. Xu, O. Erez, Z. Xu, G. Bhatti, R. Leavitt, T.H. Chung, H. El-Azzamy, C. LaJeunesse, B. Wang, A. Balogh, G. Szalai, S. Land, Z. Dong, S.S. Hassan, T. Chaiworapongsa, M. Krispin, C.J. Kim, A.L. Tarca, Z. Papp, H. Bohn:
Evolutionary origins of the placental expression of Chromosome 19 cluster galectins and their complex dysregulation in preeclampsia.
Placenta, 35, 855-865, 2014.
Impact factor: 2.710
​
25. G. Szalai, Y. Xu, R. Romero, T. Chaiworapongsa, Z. Xu, P.J. Chiang, H. Ahn, B. Sundell, O. Plazyo, Y. Jiang, M. Olive, B. Wang, S.M. Jacques, F. Qureshi, A.L. Tarca, O. Erez, Z. Dong, Z. Papp, S.S. Hassan, E. Hernandez-Andrade, N.G. Than:
In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy.
PLoS ONE, 9(11), e110867, 1-18, 2014.
Impact factor: 3.234
​
26. Sz. Szabo, M. Mody, R. Romero, Y. Xu, K. Karaszi, N. Mihalik, Z. Xu, G. Bhatti, T. Fule, P. Hupuczi, T. Krenacs, J. Rigo Jr., A.L. Tarca, S.S. Hassan, T. Chaiworapongsa, I. Kovalszky, Z. Papp, N.G. Than:
Activation of villous trophoblastic p38 and ERK1/2 signaling pathways in preterm preeclampsia and HELLP syndrome.
Pathology & Oncology Research, 21(3), 659-668, 2015.
Impact factor: 1.940
​
27. G. Szalai, R. Romero, T. Chaiworapongsa, Y. Xu, B. Wang, H. Ahn, Z. Xu, P.J. Chiang, B. Sundell, R. Wang, Y. Jiang, O. Plazyo, M. Olive, A.L. Tarca, Z. Dong, F. Qureshi, Z. Papp, S.S. Hassan, E. Hernandez-Andrade, N.G. Than:
Full-length human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice.
PLoS ONE, 10(4), e0119547, 1-42, 2015.
Impact factor: 3.057
​
28. O. Erez, R. Romero, E. Vaisbuch, J.P. Kusanovic, S. Mazaki-Tovi, T. Chaiworapongsa, F. Gotsch, P. Mittal, S.S. Edwin, C.L. Nhan-Chang, N.G. Than, C.J. Kim, S.K. Kim, L. Yeo, M. Mazor, S.S. Hassan:
The pattern and magnitude of „in vivo thrombin generation” differ in women with preeclampsia and in those with SGA fetuses without preeclampsia.
Journal of Maternal-Fetal & Neonatal Medicine, 31(13): 1671-1680, 2018.
Impact factor: 1.569
​
29. O. Erez, R. Romero, E. Vaisbuch, N.G. Than, J.P. Kusanovic, S. Mazaki-Tovi, F. Gotsch, P. Mittal, Z. Dong, T. Chaiworapongsa, C.J. Kim, C.L. Nhan-Chang, S.K. Kim, L. Yeo, M. Mazor, S.S. Hassan:
Tissue factor activity in women with preeclampsia or SGA: a potential explanation for the excessive thrombin generation in these syndromes.
Journal of Maternal-Fetal & Neonatal Medicine, 31(12): 1568-1577, 2018.
Impact factor: 1.569
​
30. L. Madar-Shapiro, I. Karady, A. Trahtenherts, A. Syngelaki, R. Akolekar, L. Poon, R. Cohen, A. Sharabi-Nov, B. Huppertz, M. Sammar, K. Juhasz, N.G. Than, Z. Papp, R. Romero, K.H. Nicolaides, H. Meiri:
Predicting the risk to develop preeclampsia in the first trimester combining promoter variant -98A/C of LGALS13 (Placental Protein 13), black ethnicity, previous preeclampsia, obesity and maternal age.
Fetal Diagnosis and Therapy,43(4), 250-265, 2018.
Impact factor: 2.040
​​
31. N.G. Than, R. Romero, A.L. Tarca, K.A. Kekesi, Y. Xu, Z. Xu, K. Juhasz, G. Bhatti, R.J. Leavitt, Zs. Gelencser, J. Palhalmi, T.H. Chung, B.A. Gyorffy, L. Orosz, A. Demeter, A. Szecsi, E. Hunyadi-Gulyas, Zs. Darula, A. Simor, K. Eder, Sz. Szabo, V. Topping, H. El-Azzamy, C. LaJeunesse, A. Balogh, G. Szalai, S. Land, O. Torok, Z. Dong, I. Kovalszky, A. Falus, H. Meiri, S. Draghici, S.S. Hassan, T. Chaiworapongsa, M. Krispin, M. Knöfler, O. Erez, G.J. Burton, C.J. Kim, G. Juhasz, Z. Papp:
Integrated systems biology approach identifies novel maternal and placental pathways of preeclampsia.
Frontiers in Immunology, 9, 1661, 2018.
Impact factor: 4.716
​
32. K. Karaszi, Sz. Szabo, K. Juhasz, P. Kiraly, B. Kocsis-Deak, B. Hargitai, T. Krenacs, P. Hupuczi, O. Erez, Z. Papp, I. Kovalszky, N.G. Than:
Increased placental expression of Placental Protein 5 (PP5) / Tissue factor pathway inhibitor-2 (TFPI-2) in women with preeclampsia and HELLP syndrome: Relevance to impaired trophoblast invasion?
Placenta, 76, 30-39, 2019.
Impact factor: 3.177
​
33. L. Orosz, G. Orosz, L. Veress, D. Dosa, L. Orosz, I. Arany, A. Fabian, L. Medve, K. Pap, Zs. Karanyi, Z. Toth, R. Poka, N.G. Than, O. Torok:
Screening for preeclampsia in the first trimester of pregnancy in routine clinical practice in Hungary.
Journal of Biotechnology, 300, 11-19, 2019.
Impact factor: 3.503
​
34. A.L. Tarca, R. Romero, N. Benshalom-Tirosh, N.G. Than, D.W. Gudicha, B. Done, P. Pacora, T. Chaiworapongsa, B. Panaitescu, D. Tirosh, N. Gomez-Lopez, S. Draghici, S.S. Hassan, O. Erez:
The prediction of early preeclampsia: Results from a longitudinal proteomics study.
PLoS ONE, 14, e0217273, 2019.
Impact factor: 2.740
​
35. N.L. Szenasi, E. Toth, A. Balogh, K. Juhasz, K. Karaszi, O. Ozohanics, Zs. Gelencser, P. Kiraly, B. Hargitai, L. Drahos, P. Hupuczi, I. Kovalszky, Z. Papp, N.G. Than:
Proteomic identification of Membrane-associated Placental Protein 4 (MP4) as perlecan and characterization of its placental expression in normal and pathologic pregnancies.
Peer J, 7: e6982, 2019.
Impact factor: 2.38
​​
36. A. Balogh, E. Toth, R. Romero, K. Parej, D. Csala, N.L. Szenasi, I. Hajdu, K. Juhasz, A.F. Kovacs, H. Meiri, P. Hupuczi, A.L. Tarca, S.S. Hassan, O. Erez, P. Zavodszky, J. Matko, Z. Papp, S.W. Rossi, S. Hahn, E. Pallinger, N.G. Than:
Placental galectins are key players in regulating the maternal adaptive immune response.
Frontiers in Immunology, 10, 1240, 2019.
Impact factor: 5.085
​​
37. A.L. Tarca, R. Romero, O. Erez, D.W. Gudicha, N.G. Than, N. Benshalom-Tirosh, P. Pacora, C.D. Hsu, T. Chaiworapongsa, S.S. Hassan, N. Gomez-Lopez:
Maternal whole blood mRNA signatures identify women at risk of early preeclampsia: a longitudinal study.
Journal of Maternal-Fetal & Neonatal Medicine, https://doi.org/10.1080/14767058.2019.1685964, January 3 2020
Impact factor: 1.737
​​
38. A. Szilagyi, Zs. Gelencser, R. Romero, Y. Xu, P. Kiraly, A. Demeter, J. Palhalmi, B.A. Gyorffy, K. Juhasz, P. Hupuczi, K.A. Kekesi, G. Meinhardt, Z. Papp, S. Draghici, O. Erez, A.L. Tarca, M. Knöfler, N.G. Than:
Placenta-specific genes, their regulation during villous trophoblast differentiation and dysregulation in preterm preeclampsia.
International Journal of Molecular Sciences, 21, 628, 2020.
Impact factor: 4.556
​
39. L. Vokalova, A. Balogh, E. Toth, S.V. Van Breda, G. Schäfer, I.M. Hoesli, O. Lapaire, S. Hahn, N.G. Than, S.W. Rossi:
Placenta Protein 13 (galectin-13) polarizes neutrophils towards an immune regulatory phenotype.
Frontiers in Immunology, 11, 145, 2020.
Impact factor: 5.085
​
40. G. Meinhardt, S. Haider, V. Kunihs, L. Saleh, J. Pollheimer, C. Fiala, Sz. Hetey, Zs. Feher, A. Szilagyi, N.G. Than, M. Knöfler:
Pivotal role of the transcriptional co-activator YAP in trophoblast stemness of the developing human placenta.
Proc. Natl. Acad. Sci. USA, 117, 13562-13570, 2020.
Impact factor: 9.412
​
41. Sz. Szabo, K. Karaszi, R. Romero, E. Toth, A. Szilagyi, Zs. Gelencser, Y. Xu, A. Balogh, G. Szalai, P. Hupuczi, B. Hargitai, T. Krenacs, E. Hunyadi-Gulyas, Zs. Darula, K.A. Kekesi, A.L. Tarca, O. Erez, G. Juhasz, I. Kovalszky, Z. Papp, N.G. Than:
Proteomic identification of Placental Protein 1 (PP1), PP8 and PP22 and characterization of their placental expression in normal pregnancies and in preeclamspia.
Placenta, 99, 197-207, 2020.
Impact factor: 3.177
​​
42. R. Gomez-Tolub, A. Rabinovich, E. Kachko, N. Benshalom-Tirosh, D. Tirosh, J. Thachil, L. Besser, N.G. Than, O. Erez:
Placental abruption as a trigger of DIC in women with HELLP syndrome: a population-based study.
Journal of Maternal-Fetal and Neonatal Medicine, 15, 1-11. September 2020.
Impact factor: 1.737
​43. A.L. Tarca, R. Romero, O. Erez, DW. Gudicha, N.G. Than, N. Benshalom-Tirosh, P. Pacora, C.D. Hsu, T. Chaiworapongsa, S.S. Hassan, N. Gomez-Lopez:
Maternal whole blood mRNA signatures identify women at risk of early preeclampsia: a longitudinal study.
Journal of Maternal-Fetal and Neonatal Medicine, 34(21): 3463-3474, 2021.
Impact factor: 2.323
​
44. A.L. Tarca, A. Taran, R. Romero, E. Jung, C. Paredes, G. Bhatti, C. Ghita, T. Chaiworapongsa, N.G. Than, C.D. Hsu:
Prediction of preeclampsia throughout gestation with maternal characteristics and biophysical and biochemical markers: a longitudinal study.
American Journal of Obstetrics and Gynecology, 226(1): 126.e1-126.e22, 2022.
Impact factor: 9.8
​
45. N.G. Than, M. Posta, D. Gyorffy, L. Orosz, G. Orosz, S.W. Rossi, G. Ambrus–Aikelin, A. Szilagyi, S. Nagy, P. Hupuczi, O. Torok, A.L. Tarca, O. Erez, Z. Papp, R. Romero:
A praeeclampsia korai betegségútvonalai, biomarkerei és négy különbözÅ‘ molekuláris alosztálya.
NÅ‘gyógyászati és Szülészeti TovábbképzÅ‘ Szemle, XXIV.(1), 6-16, 2022.
​
46. N.G. Than, M. Posta, D. Gyorffy, L. Orosz, G. Orosz, S.W. Rossi, G. Ambrus–Aikelin, A. Szilagyi, S. Nagy, P. Hupuczi, O. Torok, A.L. Tarca, O. Erez, Z. Papp, R. Romero:
Early pathways, biomarkers and four distinct molecular subclasses of preeclampsia: the intersection of clinical, pathological
and high-dimensional studies.
Placenta (Trophoblast Research) 125, 10-19, 2022.
Impact factor: 3.8
​
47. N.G. Than, R. Romero, D. Gyorffy, M. Posta, G. Bhatti, B. Done, P. Chaemsaithong, E. Jung, M. Suksai, F. Gotsch, D.M. Gallo, M. Bosco, B. Kim, Y.M. Kim, T. Chaiworapongsa, S.W. Rossi, A. Szilagyi, O. Erez, A.L. Tarca, Z. Papp
Molecular subclasses of preeclampsia characterized by a longitudinal maternal proteomics study: distinct biomarkers, disease pathways and options for prevention
J. Perinat. Med. 2023; 51(1): 51–68
Impact factor: 2.4
​
48. O.Erez, F. Gotsch, E. Jung, T. Chaiworapongsa, D.W. Gudicha, M. Suksai, D.M. Gallo, P. Chaemsaithong, M. Bosco, M. Al Qasem, A. Meyyazhagan, N.G. Than, R. Romero
Perturbations in kinetics of the thrombin generation assay identify women at risk of preeclampsia in the first trimester and provide the rationale for a preventive approach.
American Journal of Obstetrics and Gynecology, 228(5):580.e1-580.e17, 2023.
Impact factor: 9.8
​
49. N.G. Than, R. Romero, M. Posta, D. Gyorffy, G. Szalai, S.W. Rossi, A. Szilagyi, P. Hupuczi, S. Nagy, O. Torok, A.L. Tarca, O. Erez, N. Acs, Z. Papp
Classification of preeclampsia according to molecular clusters with the goal of achieving personalized prevention
Journal of Reproductive Immunology 161 (2024) 104172
Impact factor: 3.4.
​
50. L. Gal, A. Fothi, G. Orosz, S. Nagy, N.G. Than, T.I. Orban
Exosomal small RNA profiling in first-trimester maternal blood explores early molecular pathways of preterm preeclampsia
Frintiers in Immunology, 22 February 2024. Volume 15-2024
Impact factor: 7.3.
Review Papers
​
1. J. Espinoza, R. Romero, Y.M. Kim, J.P. Kusanovic, S. Hassan, O. Erez, F. Gotsch, N.G. Than, Z. Papp, C.J. Kim:
Normal and abnormal transformation of the spiral arteries during pregnancy.
Journal of Perinatal Medicine. 34, 447-458, 2006.
Impact factor: 1.000
​
2. R. Romero, J. Espinoza, F. Gotsch, J.P. Kusanovic, L.A. Friel, O. Erez, S. Mazaki-Tovi, N.G. Than, S. Hassan, G. Tromp:
The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome.
BJOG, 113 Suppl 3, 118-135, 2006.
Impact factor: 2.126
​
3. N.G. Than, R. Romero, C.J. Kim, M.R. McGowen, Z. Papp, D.E. Wildman:
Galectins: guardians of eutherian pregnancy at the maternal-fetal interface.
Trends in Endocrinology and Metabolism, 23(1), 23-31, 2012.
Impact factor: 8.901
​
4. N.G. Than, A. Balogh, R. Romero, E. Karpati, O. Erez, A. Szilagyi, I. Kovalszky, M. Sammar, S. Gizurarson, J. Matko, P. Zavodszky, Z. Papp, H. Meiri:
Placental Protein 13 (PP13) – a placental immunoregulatory galectin protecting pregnancy.
Frontiers in Immunology, invited review, 5, Article 348, 1-25, 2014.
​
5. N.G. Than, R. Romero, A. Balogh, E. Karpati, S.A. Mastrolia, O. Staretz-Chacham, S. Hahn, O. Erez, Z. Papp, C.J. Kim:
Galectins: Double-edged swords in the cross-roads of pregnancy complications and female reproductive tract inflammation and neoplasia.
Journal of Pathology and Translational Medicine, invited review, 49, 181-208, 2015.
​
6. S. Hahn, O. Lapaire, N.G. Than:
Biomarker development for presymptomatic molecular diagnosis of preeclampsia: Feasible, useful or even unnecessary?
Expert Review of Molecular Diagnostics, invited review, 15, 617-629, 2015.
Impact factor: 3.333
​
7. S. Giaglis, M. Stoikou, F. Grimolizzi, B.Y. Subramanian, S.V. van Breda, I. Hoesli, O. Lapaire, P. Hasler, N.G. Than, S. Hahn:
Neutrophil migration into the placenta: Good, bad or deadly?
Cell Adhesion & Migration, 10(1–2), 208-225, 2016.
Impact factor: 3.872
​
8. M. Stavski, O. Mor, S.A. Mastrolia, S. Greenbaum, N.G. Than, O. Erez:
Cerebral palsy – Trends in epidemiology and recent development in prenatal mechanisms of disease, treatment and prevention.
Frontiers in Pediatrics, 5, 21, 2017.
Impact factor: 2.335
​
9. L. Vokalova, S.V. van Breda, X.L. Ye, E.A. Huhn, N.G. Than, P. Hasler, O. Lapaire, I. Hoesli, S.W. Rossi, S. Hahn:
Excessive neutrophil activity in gestational diabetes mellitus: Could it contribute to the development of preeclampsia?
Frontiers in Endocrinology, 9: 542, 2018.
Impact factor: 3.634
​
10. S. Hahn, P. Hasler, L. Vokalova, S.V. van Breda, O. Lapaire, N.G. Than, I. Hoesli, S.W. Rossi:
The role of neutrophil activation in determining the outcome of pregnancy and modulation by hormones and/or cytokines.
Clinical Experimental Immunology, 198, 24-36, 2019.
Impact factor: 3.532
​​
11. S. Hahn, P. Hasler, L. Vokalova, S.V. van Breda, N.G. Than, I.M. Hoesli, O. Lapaire, S.W. Rossi:
Feto-maternal microchimerism: The pre-eclampsia conundrum.
Frontiers in Immunology, 10: 659, 2019.
Impact factor: 5.085
​
12. E. Menkhorst, N.G. Than, U. Jeschke, G. Barrientos, L. Szereday, G. Dveksler, S.M. Blois:
Medawar's PostEra: Galectins Emerged as Key Players During Fetal-Maternal Glycoimmune Adaptation.
Frontiers in Immunology, 12: 784473, 2021.
Impact factor: 8.786
​
eBook
​​
1. Fetal-Maternal Immune Interactions in Pregnancy. Frontiers in Immunology, Eds. N.G. Than, S. Hahn, S.W. Rossi, J. Szekeres-Bartho
2019, ISBN 978-2-88963-242-8, DOI 10.3389/978-2-88963-242-8, ISSN 16648714
​​
Editorial
​
1. N.G. Than, S. Hahn, S.W. Rossi, J. Szekeres-Bartho.
Editorial: Fetal-Maternal Immune Interactions in Pregnancy.
Frontiers in Immunology, 10 2729, 2019.
Impact factor: 5.085
​
Book Chapter
​​
1. N.G. Than, E. Vaisbuch, C.J. Kim, S. Mazaki-Tovi, O. Erez, L. Yeo, P. Mittal, P. Hupuczi, T. Varkonyi, S.S. Hassan, Z. Papp, R. Romero:
Early-onset preeclampsia and HELLP syndrome: an overview.
In: Handbook of Growth and Growth Monitoring in Health and Disease,
Ed.: Preedy V.R., Springer, Chapter 113, 1867-1891, 2012.
​
2. O. Erez, T. Lanxberg, T.R. Yehudai, L. Bessor, E. Laron, N.G. Than, A. Wiznitzer:
Spontaneous Preterm Labor & Delivery. In: Clinical Obstetrics: The Fetus & Mother. Ed.: E.A. Reece, G.F. Leguizamon, G.A. Macones, A. Wiznitzer. 4th ed. Wolters Kluwer; Chapter 49, 544-565, 2021.
​​
Invited Commentary
​​
1. N.G. Than:
PP13, decidual zones of necrosis, and spiral artery remodeling – preeclampsia revisited?
Reproductive Sciences, 19, 14-15, 2012.
